BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 9402087)

  • 1. Mutations in the vasopressin V2 receptor and aquaporin-2 genes in 12 families with congenital nephrogenic diabetes insipidus.
    Vargas-Poussou R; Forestier L; Dautzenberg MD; Niaudet P; Déchaux M; Antignac C
    J Am Soc Nephrol; 1997 Dec; 8(12):1855-62. PubMed ID: 9402087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation between AVPR2 mutations and urinary AQP2 excretion in patients with nephrogenic diabetes insipidus.
    Kotnik P; Battelino T; Debeljak M; Podkrajsek KT; Waldhauser F; Frøkiaer J; Nielsen S; Krzisnik C
    J Pediatr Endocrinol Metab; 2007 Apr; 20(4):483-9. PubMed ID: 17550212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic forms of nephrogenic diabetes insipidus (NDI): Vasopressin receptor defect (X-linked) and aquaporin defect (autosomal recessive and dominant).
    Bichet DG; Bockenhauer D
    Best Pract Res Clin Endocrinol Metab; 2016 Mar; 30(2):263-76. PubMed ID: 27156763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [From genes to disease: from vasopressin-V2-receptor and aquaporine-2 to nephrogenic diabetes insipidus].
    Knoers NV; Deen PM
    Ned Tijdschr Geneeskd; 2000 Dec; 144(50):2402-4. PubMed ID: 11145096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification and characterization of aquaporin-2 water channel mutations causing nephrogenic diabetes insipidus with partial vasopressin response.
    Canfield MC; Tamarappoo BK; Moses AM; Verkman AS; Holtzman EJ
    Hum Mol Genet; 1997 Oct; 6(11):1865-71. PubMed ID: 9302264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patients with autosomal nephrogenic diabetes insipidus homozygous for mutations in the aquaporin 2 water-channel gene.
    van Lieburg AF; Verdijk MA; Knoers VV; van Essen AJ; Proesmans W; Mallmann R; Monnens LA; van Oost BA; van Os CH; Deen PM
    Am J Hum Genet; 1994 Oct; 55(4):648-52. PubMed ID: 7524315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutations in the vasopressin V2 receptor and aquaporin-2 genes in twelve families with congenital nephrogenic diabetes insipidus.
    Vargas-Poussou R; Forestier L; Dautzenberg MD; Niaudet P; Déchaux M; Antignac C
    Adv Exp Med Biol; 1998; 449():387-90. PubMed ID: 10026829
    [No Abstract]   [Full Text] [Related]  

  • 8. Novel mutations underlying nephrogenic diabetes insipidus in Arab families.
    Carroll P; Al-Mojalli H; Al-Abbad A; Al-Hassoun I; Al-Hamed M; Al-Amr R; Butt AI; Meyer BF
    Genet Med; 2006 Jul; 8(7):443-7. PubMed ID: 16845277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nephrogenic diabetes insipidus due to a novel AVPR2 mutation.
    Sakallioglu O; Tascilar ME; Kalman S; Cheong HI; Atay AA
    J Pediatr Endocrinol Metab; 2009 Feb; 22(2):187-9. PubMed ID: 19449677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Normal fibrinolytic responses to 1-desamino-8-D-arginine vasopressin in patients with nephrogenic diabetes insipidus caused by mutations in the aquaporin 2 gene.
    van Lieburg AF; Knoers VV; Mallmann R; Proesmans W; van den Heuvel LP; Monnens LA
    Nephron; 1996; 72(4):544-6. PubMed ID: 8730418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional characterization of the molecular defects causing nephrogenic diabetes insipidus in eight families.
    Pasel K; Schulz A; Timmermann K; Linnemann K; Hoeltzenbein M; Jääskeläinen J; Grüters A; Filler G; Schöneberg T
    J Clin Endocrinol Metab; 2000 Apr; 85(4):1703-10. PubMed ID: 10770218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical and laboratory characteristics of arginine vasopressin resistance, caused by a new homozygous mutation p.R113C in AQP2].
    Makretskaya NA; Nanzanova US; Hamaganova IR; Eremina ER; Tiulpakov AN
    Probl Endokrinol (Mosk); 2023 May; 69(2):75-79. PubMed ID: 37448274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular analyses of the vasopressin type 2 receptor and aquaporin-2 genes in Brazilian kindreds with nephrogenic diabetes insipidus.
    Rocha JL; Friedman E; Boson W; Moreira A; Figueiredo B; Liberman B; de Lacerda L; Sandrini R; Graf H; Martins S; Puñales MK; De Marco L
    Hum Mutat; 1999; 14(3):233-9. PubMed ID: 10477431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Novel Missense Mutation of Arginine Vasopressin Receptor 2 in a Chinese Family with Congenital Nephrogenic Diabetes Insipidus: X-Chromosome Inactivation in Female CNDI Patients with Heterozygote 814A>G Mutation.
    Zang L; Gong Y; Li Y; Dou J; Lyu Z; Su X; Zhang Y; Mu Y
    Biomed Res Int; 2022; 2022():7073158. PubMed ID: 35865667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vasopressin receptor mutations causing nephrogenic diabetes insipidus.
    Bichet DG; Turner M; Morin D
    Proc Assoc Am Physicians; 1998; 110(5):387-94. PubMed ID: 9756088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two novel mutations in the aquaporin 2 gene in a girl with congenital nephrogenic diabetes insipidus.
    Cheong HI; Cho SJ; Zheng SH; Cho HY; Ha IS; Choi Y
    J Korean Med Sci; 2005 Dec; 20(6):1076-8. PubMed ID: 16361827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular biology of diabetes insipidus.
    Fujiwara TM; Morgan K; Bichet DG
    Annu Rev Med; 1995; 46():331-43. PubMed ID: 7541187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nephrogenic diabetes insipidus.
    Bichet DG
    Adv Chronic Kidney Dis; 2006 Apr; 13(2):96-104. PubMed ID: 16580609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Novel Mutation in the
    Çelebi Tayfur A; Karaduman T; Özcan Türkmen M; Şahin D; Çaltık Yılmaz A; Büyükkaragöz B; Buluş AD; Mergen H
    J Clin Res Pediatr Endocrinol; 2018 Nov; 10(4):350-356. PubMed ID: 29991464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular and cellular defects in nephrogenic diabetes insipidus.
    Knoers NV; van Os CH
    Curr Opin Nephrol Hypertens; 1996 Jul; 5(4):353-8. PubMed ID: 8823534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.